Healthcare Industry Trends and Updates

“The eye exam equipment market is projected to grow at a CAGR of 6.0% between 2017 and 2022.” The eye exam equipment market is expected to reach USD 3.05 billion by 2022 from USD 2.29 billion in 2017, at a CAGR of 6.0% from 2017 to 2022. Rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and increasing healthcare expenditure and rising disposable incomes are some of the major factors driving the growth of this market. However, the high cost of eye examination equipment, lack of awareness on and low accessibility to eye care in low-income economies, and increasing adoption of refurbished eye exam equipment may hinder the growth of this market to a certain extent. “Retina and glaucoma examination products segment to witness the highest growth rate during the forecast period.” On the basis of type, the retina and glaucoma examination products segment is expected to register the highest

The global live cell encapsulation technology market is estimated to grow at a high rate during the forecast period. A number of factors such as increasing incidence of various types of cancers (such as pancreatic, breast, and brain), rising prevalence of diabetes, and rising adoption of cell encapsulation technology to develop treatments for cancer and diabetes are fuelling the growth of the global live cell encapsulation technology market. However, lack of clinical-grade polymers; production of uniform capsules; ethical, political, and regulatory issues; and other technological and biological limitations are some of the major challenges that needs to be overcome by the key players to sustain in this market. Cell encapsulation technology enables to overcome the existing issue of graft rejection in tissue engineering applications. It helps to minimize the requirement for long-term use of immuno-suppressive drugs after an organ transplant in order to control side effects. This tec

Analysis of the developments in the temperature monitoring systems market from 2016 to 2018 shows that new product launches, geographic expansions, mergers & acquisitions, and contracts were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positions. Some of the prominent players in the temperature monitoring systems market are 3M (US), Abb Ltd. (Switzerland), Deltatrack (US), Emerson Electric (US), Fluke Corporation (Subsidiary Of Fortive Corporation) (US), Honeywell (US), Kelsius, Ltd. (Ireland), Monnit Corporation (US), and Omega Engineering (US). The growth of this market is driven by rising manufacturing activity across a range of industries, as well as stringent regulations to ensure product quality (particularly in the food & beverage and pharmaceutical sectors). Technological advancements have introduced systems that are more efficient and capable of meeting a greater variety of needs

Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel) are the leading players in digital diabetes management market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, approvals, and enhancements; expansions; agreements, collaborations, and partnerships; and mergers & acquisitions. The global digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%. Factors such as the rising prevalence of diabetes, technological advancements, increasing adoption of cloud-based enterprise solutions, and the growing use of connected devices and apps are driving the growth

Key players in the global epigenetics market , such as Illumina, Thermo Fisher, Diagenode, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, and PerkinElmer, are focusing on increasing their presence in the high-growth markets through organic as well as inorganic strategies such as product launches, partnerships, agreements, collaborations, expansions, and acquisitions. The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the in the coming years.  According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies

The global hybrid operating room market is expected to grow at a CAGR of 12.5% between 2017 and 2022. Factors driving the growth of this market include the increasing adoption of minimally invasive surgical procedures and technological advancements among others. As of 2016, Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.), Toshiba Corporation (Japan), GE Healthcare (U.S.), IMRIS Inc. (U.S.), Eschmann Equipment (U.K.), MAQUET GmbH (Germany), Trumpf Medical (Germany), and Skytron LLC (U.S.), Richard Wolf GmbH (Germany), MIZUHO OSI (U.S.), STERIS plc. (U.S.), NDS Surgical Imaging (U.S.), Alvo (Poland) are some of the major manufacturers in hybrid operating room market . Analysis of the market developments between 2014 and 2017 (March) show that new product launch, agreements, and collaborations were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positio

The global ostomy care accessories market is estimated to be valued at USD 2.40 Billion in 2017 and is projected to reach USD 2.99 Billion by 2022, growing at a CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are factors driving the growth of the ostomy care market. Analysis of the ostomy care accessories market developments between 2015 and 2017 revealed that several growth strategies such as product launches and product enhancements, strategic acquisitions, agreements, contracts, and market expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the ostomy care market. Among these business strategies, product launches and product enhancements were th

“The increasing adoption of targeted therapy over traditional therapy is expected to drive the overall growth of the immuno-oncology assays market.” The immuno oncology assays market is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The immuno-oncology assays market is driven primarily by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period. “The lung cancer segment is expected to grow at the highest CAGR during the forecast period.”   Based on indication, the immuno-oncology assays market is segmented into lung cancer, colorectal cancer, melanoma, bladder cancer, and other cancers. The lung cancer segment is expected to be th

The temperature monitoring systems market is projected to reach USD 5.4 billion by 2024 from USD 4.5 billion in 2019, at a CAGR of 3.9%. The growth of this market is driven by rising manufacturing activity across a range of industries, as well as stringent regulations to ensure product quality (particularly in the food & beverage and pharmaceutical sectors). Technological advancements have introduced systems that are more efficient and capable of meeting a greater variety of needs than their predecessors did, which has stimulated their overall adoption. In healthcare, the growing patient population and increasing disease prevalence are direct drivers of market growth. Rising R&D activity is also expected to contribute to market prospects in the coming years. In this report, the global temperature monitoring systems market has been segmented into type, application, end user, and region. Based on type, the temperature monitoring systems market is segmented into contact-base

“The global healthcare analytical testing services market projected to grow at a CAGR of 11.7%.” The healthcare analytical testing services market is expected to reach USD 5.97 billion by 2023 from an estimated USD 3.43 billion in 2018, at a CAGR of 11.7%. The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the market. However, factors such as the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry are limiting the adoption of healthcare analytical testing services up to some extent during the forecast period.   “The batch-release testing segment is expected to register the highest CAGR during the forecast period. ” On the basis of

The growth of the  urology surgical instruments market  is likely to be centered at the Asia-Pacific region due to favorable prospects for the growth of the urology surgical instruments market, growing healthcare industry in Japan, government investments to improve medical infrastructure and increase the number of doctors, penetration of key players into the Chinese market, growing preference for minimally invasive surgeries & improving healthcare infrastructure, German-Asian partnerships stimulating market growth in Asia, Asian countries—leading medical tourism destinations, growing number of hospitals in Singapore and South Korea, changing regulatory and healthcare scenario in Vietnam, favorable healthcare system in Australia, and stringent regulations to limit market growth in Malaysia & Indonesia. Favorable prospects for growth of the urology surgical instruments market in Japan include regional offices of major players of the market,  trade agreements, the increasing nu

The  Cell Sorting Market  is expected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% from 2016 to 2021. The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW). A number of factors such as technological advancements in cell sorters, growing adoption of cell sorter techniques in research activities, rising funding and investments for development of innovative cell sorting techniques, growing prevalence of HIV/AIDS and cancer, and launch of specific reagents for specific applications are fueling the growth of the cell sorting market. On the other hand, lack of awareness and technical knowledge regarding the use of cell sorters and high cost of instruments are some of the key factors limiting the growth of the global cell sorting market. Cell sorters are utilized for separation and purification of various cell populations and sub-populations from a complex mixtur

The global plastic surgery instruments market is expected to reach USD 1.47 billion by 2023 from USD 1.00 billion in 2018, at a CAGR of 8.1%. Increasing awareness and demand for cosmetic surgeries, growing number of age-related surgeries across the globe, and increasing incidence of cancer are the key drivers for the global plastic surgery instruments market. The plastic surgery instruments market is segmented on the basis of type, procedure, end user, and region. By type, the market is segmented into handheld instruments, electrosurgical instruments, and other plastic surgery instruments. The electrosurgical instruments segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the factors such as technological advancements, new product launches, and the growing demand for reducing the operating time of surgeries. On the basis of procedure, the plastic surgery instruments market is segmented into cosmetic surgery

The global cranial fixation and stabilization systems market is valued at USD 1.06 Billion in 2016 and is projected to reach USD 1.74 Billion by 2022, at a CAGR of 8.7%. The study estimates the cranial fixation and stabilization systems market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include research neurosurgeons, medical researchers, hospital purchase manager, and academic research institutes. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the cranial fixation and stabilization systems market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in ext

The digital diabetes management market is projected to reach USD 19.9 billion by 2024 from an estimated USD 6.8 billion in 2019, at a CAGR of 23.8%. The major factors driving the growth of this market include the rising prevalence of diabetes, technological advancements, increasing adoption of cloud-based enterprise solutions, and the growing use of connected devices and apps. North America, the largest regional market for digital diabetes management North America accounted for the largest share of the digital diabetes management market in 2018, followed by Europe and the Asia Pacific. Factors such as growing adoption of connected diabetes management devices, high adoption of diabetes management apps, growing demand for integrated hybrid closed-loop systems, favorable reimbursement policies, and government initiatives to promote digital health in the region are driving the growth of the digital diabetes management market in North America. Download PDF Brochure:  https://www.mar

The Cell Sorting Market is expected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% from 2016 to 2021. The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW). A number of factors such as technological advancements in cell sorters, growing adoption of cell sorter techniques in research activities, rising funding and investments for development of innovative cell sorting techniques, growing prevalence of HIV/AIDS and cancer, and launch of specific reagents for specific applications are fueling the growth of the cell sorting market. On the other hand, lack of awareness and technical knowledge regarding the use of cell sorters and high cost of instruments are some of the key factors limiting the growth of the global cell sorting market. Cell sorters are utilized for separation and purification of various cell populations and sub-populations from a complex mixture o

According to a new market research report  " Mass Spectrometry Market  by Platform (Hybrid mass spectrometry (Triple Quadrupole, QTOF & FTMS), Single mass spectrometry (Quadrupole, TOF & Ion Trap)), Application (Pharmaceuticals, Biotechnology, Environmental testing) - Global Forecast to 2022",  published by MarketsandMarkets™, the market is expected to reach USD 5.27 Billion by 2022 from an estimated USD 3.68 Billion in 2017, at a CAGR of 7.4%. The key factors which include the growth of the mass spectrometry market are pharmaceutical and biotechnology industry and technological advancements in mass spectrometry. The growing use of mass spectrometry in emerging markets and the rising potential for the application of high-resolution mass spectrometry in healthcare are the key areas of opportunity in this market. Sciex under Danaher Corporation (US) dominated the mass spectrometry market in 2016. The company provides a wide range of mass spectrometry technologies,

The global dental bone graft substitutes market is expected to reach USD 664.3 million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as growing aging population, growing medical and dental tourism in developing countries, and increasing disposable income in developing countries across the globe are fueling the growth of this market. The major players operating in global dental bone graft substitutes market include Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea). The global dental bone graft substitutes market is fragmented and competitive, with a significant number of global and regional market players. This report studies the growth strategies adopted by key market players between 2013 and 2015. Leading players in the dental bone graft subst

The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of this market. Agreements, partnerships, and collaborations accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include Mimetas (Netherlands), Emulate (US), and Lonza (Switzerland). The 3D cell culture market is highly competitive with several big and small players. Prominent players in this market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US.), Synthe

The global microplate system market is expected to reach USD 996.9 Million by 2022 from USD 820.3 Million in 2017, at a CAGR of 4.0%. This market is experiencing significant growth due to increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. Collaborations, agreements, & partnerships accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include PerkinElmer (US), Danaher (US), Tecan (Switzerland), Thermo Fisher (US), BMG LABTECH (UK), Agilent (US), and Biochrom (UK). The microplate systems market is highly competitive with the presence of several big and small players. In 2016, Tecan (Switzerland), Bio-Rad (US), Thermo Fisher (US), Danaher (US), and PerkinElmer (US) were the leading players in the microplate systems market. Other major players include BioTek (U

Medtronic plc accounted for the largest share of the pain management devices market due to its dominant position in the neurostimulation market. Its wide portfolio of infusion systems and spinal cord stimulation devices, which are used in chronic pain management, is one of the important factors responsible for its leading position and future growth in the pain management devices industry. Furthermore, the company’s wide geographic presence enables it to maintain its strong position in the market. The company expanded its research capabilities by establishing several training and research facilities in developing countries. In 2014, it established the Covidien Center of Innovation Brazil (CCI), Covidien Center of Innovation Turkey (CCI Turkey), and Covidien Center of Innovation Korea (CCI Korea). This helped the company to intensify its research activities, strengthen its product portfolio, increase its global reach, and strengthen its position in the pain management devices market.

Healthcare analytical testing services are used by pharmaceutical, biopharmaceutical, and medical device manufacturers for providing support to all stages of the drug development process, from discovery through preclinical & clinical development to commercial manufacture. The healthcare analytical testing services market is expected to reach USD 5.97 Billion by 2023 from USD 3.09 Billion in 2017, at a CAGR of 11.7%. The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the market. The global healthcare analytical testing services market by end user is segmented into pharmaceutical and biopharmaceutical companies, medical device companies and contract research organizations. In 2017, the pharmaceutical and biopha

Neuromodulation is a technique that acts directly on nerves or the target area, where the activity of nerves is altered. These alterations are due to the effects produced by electrical stimulation or drug infusion. These devices include small electrodes, which are placed in the brain, spinal cord, or peripheral nerves, and are connected via leads to an implantable pulse generator placed under the skin to generate electrical stimulation in a precise pattern. The global neuromodulation market is segmented on the basis of technology, application, and region.  Based on technology, the market is segmented into internal  and external neuromodulation. Internal neuromodulation is further segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES). External neuromodulation is categorized into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stim

The global  dental bone graft substitutes market ​ is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as growing aging population, growing medical and dental tourism in developing countries, and increasing disposable income in developing countries across the globe are fueling the growth of this market. The major players operating in global dental bone graft substitutes market include Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea). The global dental bone graft substitutes market is fragmented and competitive, with a significant number of global and regional market players. This report studies the growth strategies adopted by key market players between 2013 and 2015. Leading players in the dental bone graft su